BAMBEVI
Analogs of BAMBEVI
Find cheaper analogs and generic equivalents for BAMBEVI.
Active Ingredient: BEVACIZUMAB
Product Overview
About BAMBEVI
BAMBEVI is a medicine that contains the active ingredient BEVACIZUMAB, which is used to treat various serious medical conditions. BEVACIZUMAB is a recombinant humanized monoclonal antibody that works by inhibiting the growth of new blood vessels, thereby reducing the supply of nutrients to tumors. BAMBEVI is administered via intravenous infusion and is used in the treatment of certain types of cancer.
Key Benefits & Uses
- Treatment of metastatic colorectal cancer
- Treatment of non-small cell lung cancer
- Treatment of glioblastoma, a type of brain cancer
Active Ingredient & Action
BEVACIZUMAB, the active ingredient in BAMBEVI, is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), a protein that promotes the formation of new blood vessels. By binding to VEGF, BEVACIZUMAB prevents the interaction between VEGF and its receptors, thereby inhibiting the growth of new blood vessels and reducing the supply of nutrients to tumors.
Important Notes
It is essential to follow the dosage and administration instructions provided by a healthcare professional when taking BAMBEVI. Patients should also be monitored for potential side effects, such as hypertension, proteinuria, and bleeding. BAMBEVI should only be used under the guidance of a qualified healthcare professional, and patients should report any adverse reactions or concerns to their doctor.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.